Scientific Publications Database
Article Title: Year one interim analysis results of the Phase IIIb CHORDS study evaluating ocrelizumab effectiveness and safety in patients with relapsing-remitting multiple sclerosis who had suboptimal response with prior diseasemodifying treatmentsAuthors: Leist, T. P.; Reder, A. T.; Bermel, R.; Weinstock-Guttman, B.; Freedman, M. S.; Cutter, G.; Stankiewicz, J.; Zheng, H.; Musch, B.; Csoboth, C.; Wolinsky, J. S.
Journal: MULTIPLE SCLEROSIS JOURNAL Volume 24
Date of Publication:2018
Abstract:
.